BMS Gets EU nod for Cancer Drugs

19.05.2016 - Bristol-Myers Squibb (BMS) and AbbVie’s cancer treatment Empliciti has received the green light in Europe to treat multiple myeloma, a blood cancer that develops in the bone marrow...